Migraine prophylaxis is a demonstrated viable therapeutic option, providing positive results through the use of drugs, more and more safe and effective. These drugs are anticonvulsant, antidepressant, calcium channel blockers, beta blockers, making a notable contribution according to studies reported in the literature. But they also have side effects, usually less than their efficacy. In this study we report our series of migraineurs with and without aura, treated with prophylactic drugs. In the study we used the drugs of first choice and we used VAS scale to assess pain intensity, checking patients for 8 months, with good results, in some cases excellent. Data from literature show that these new nutraceutical substances, besides to those already in use, are utilized successfully, opening new therapeutic perspectives. Do not resort to symptomatic drugs, it is very important, being rich in adverse, potentially harmful effects, so migraine prophylaxis remains a useful instrument of defense in these patients.
Domenico Chirchiglia, Attilio Della Torre, Carmelino Angelo Stroscio and Angelo Lavano
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : April 19, 2018